SCHEMBL26847351

SCHEMBL26847351

N#Cc1c(-c2cccs2)cc(=O)[nH]c1SCC1=NC(=O)CN1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 8/20 0.45
▸ PIM1 P11309 2/20 0.45
▸ ALDH1A1 P00352 9/20 0.41
▸ HPGD P15428 7/20 0.41
▸ HSD17B10 Q99714 4/20 0.41
▸ GAA P10253 3/20 0.41
▸ GLA P06280 2/20 0.41
▸ CASP1 P29466 1/20 0.41
▸ ADORA2A P29274 3/20 0.41
▸ ADORA1 P30542 3/20 0.41
▸ MAPT P10636 6/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ RXFP1 Q9HBX9 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ HCRTR1 O43613 1/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ NPSR1 Q6W5P4 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ PRNP P04156 3/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847383 0.84 NPSR1 (0.42) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL24087881 0.76 KDM4E (0.45) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL26847333 0.76 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL26847199 0.76 ACMSD (0.48) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL24087956 0.75 KDM4E (0.46) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL26847345 0.75 KDM4E (0.46) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL23183523 0.74 KDM4E (0.58) KDM4EPIM1ALDH1A1HPGDHSD17B10
SCHEMBL23850235 0.73 ACMSD (0.64) KDM4EPIM1ALDH1A1HPGDADORA2A
SCHEMBL20339975 0.73 ACMSD (0.64) KDM4EPIM1ALDH1A1HPGDADORA2A
SCHEMBL20340083 0.73 ACMSD (0.49) KDM4EPIM1ALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 KDM4E 1110/4885PIM1 4131/4885ALDH1A1 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback